[{"address1": "Wagistrasse 14", "city": "Schlieren", "zip": "8952", "country": "Switzerland", "phone": "41 44 755 77 00", "fax": "41 44 755 77 07", "website": "https://www.molecularpartners.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Molecular Partners AG, a clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland. Its product pipeline comprises MP0317, which is in Phase 1 clinical trial for the treatment of advanced solid tumors; MP053, novel tetra-specific T cell-engaging DARPin, which is phase 1 clinical trial for the treatment of acute myeloid leukemia; and MP0712, a 212Pb Radio-DARPin therapy (RDT) candidate targeting the tumor-associated protein delta-like ligand 3 (DLL3) which is in preclinical trial to treat SCLC and neuroendocrine tumors. It also researches for Switch-DARPin T cell engager to treat CD3 x costim x; and Radio-DARPin Therapy to treat ovarian disease. In addition, the company develops MP0621, a molecular partners' first Switch-DARPin program, which is in preclinical trial designed to induce killing of hematopoietic stem cells (HSCs) as a next-generation conditioning regimen for HSC transplantation (HSCT); and Radio-DARPin Therapy (RDT) platform, a delivery system for effective and selective delivery of radioactive payloads to solid tumors. It has collaboration agreement with Orano Med SAS to develop novel Radio-DARPin therapeutics and an additional six targeted alpha therapeutics candidates. Molecular Partners AG was incorporated in 2004 and is headquartered in Schlieren, Switzerland.", "fullTimeEmployees": 158, "companyOfficers": [{"maxAge": 1, "name": "Dr. Patrick  Amstutz Ph.D.", "age": 49, "title": "Co-Founder, CEO, Member of Management Board & Director", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 811271, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael Tobias Stumpp Ph.D.", "age": 52, "title": "Co-Founder, Executive VP of Projects & Member of Management Board", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Hendriks", "title": "Senior VP of Finance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alexander  Zurcher", "age": 49, "title": "COO & Member of Management Board", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Renate  Gloggner", "age": 54, "title": "Executive VP of People & Community and Member of Management Board", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Philippe  Legenne M.B.A., M.D.", "age": 58, "title": "Chief Medical Officer & Member of the Management Board", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Steiner Ph.D.", "title": "Senior Vice President of Research & Technology", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Martin  Steegmaier Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Seth D. Lewis", "title": "Senior Vice President of Investor Relations, Communications & Strategy", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Pitzner", "title": "General Counsel, Compliance Officer, Senior VP Legal & Business Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.515, "open": 4.3901, "dayLow": 4.3901, "dayHigh": 4.5243, "regularMarketPreviousClose": 4.515, "regularMarketOpen": 4.3901, "regularMarketDayLow": 4.3901, "regularMarketDayHigh": 4.5243, "payoutRatio": 0.0, "beta": 0.563, "forwardPE": -2.4565217, "volume": 1214, "regularMarketVolume": 1214, "averageVolume": 4977, "averageVolume10days": 2560, "averageDailyVolume10Day": 2560, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 169044160, "fiftyTwoWeekLow": 3.36, "fiftyTwoWeekHigh": 5.948, "allTimeHigh": 32.04, "allTimeLow": 3.32, "priceToSalesTrailing12Months": "Infinity", "fiftyDayAverage": 3.95062, "twoHundredDayAverage": 3.91663, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 66055168, "profitMargins": 0.0, "floatShares": 17489339, "sharesOutstanding": 37399152, "sharesShort": 24337, "sharesShortPriorMonth": 29045, "sharesShortPreviousMonthDate": 1760486400, "dateShortInterest": 1763078400, "sharesPercentSharesOut": 0.0007, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.095790006, "shortRatio": 2.69, "shortPercentOfFloat": 0.0013, "impliedSharesOutstanding": 37399152, "bookValue": 2.554, "priceToBook": 1.769773, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -60234000, "trailingEps": -2.02, "forwardEps": -1.84, "enterpriseToEbitda": -1.164, "52WeekChange": -0.19518715, "SandP52WeekChange": 0.13287461, "quoteType": "EQUITY", "currentPrice": 4.52, "targetHighPrice": 16.84896, "targetLowPrice": 3.9910014, "targetMeanPrice": 10.661107, "targetMedianPrice": 10.902232, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 104521000, "totalCashPerShare": 2.795, "ebitda": -56742000, "totalDebt": 1532000, "quickRatio": 9.081, "currentRatio": 9.28, "totalRevenue": 0, "debtToEquity": 1.604, "revenuePerShare": 0.0, "returnOnAssets": -0.27014, "returnOnEquity": -0.51415, "grossProfits": -40403000, "freeCashflow": -27220124, "operatingCashflow": -53301000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CHF", "symbol": "MOLN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Molecular Partners AG", "longName": "Molecular Partners AG", "regularMarketChangePercent": 0.11074451, "regularMarketPrice": 4.52, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-06-16", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1764968642, "regularMarketTime": 1764968400, "exchange": "NMS", "messageBoardId": "finmb_32677064", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1623850200000, "postMarketChangePercent": -4.6460185, "postMarketPrice": 4.31, "postMarketChange": -0.21000004, "regularMarketChange": 0.0050001144, "regularMarketDayRange": "4.3901 - 4.5243", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 4977, "fiftyTwoWeekLowChange": 1.1600001, "fiftyTwoWeekLowChangePercent": 0.34523812, "fiftyTwoWeekRange": "3.36 - 5.948", "fiftyTwoWeekHighChange": -1.428, "fiftyTwoWeekHighChangePercent": -0.2400807, "fiftyTwoWeekChangePercent": -19.518715, "earningsTimestampStart": 1756152000, "earningsTimestampEnd": 1756152000, "earningsCallTimestampStart": 1741345140, "earningsCallTimestampEnd": 1741345140, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.02, "epsForward": -1.84, "epsCurrentYear": -1.59, "priceEpsCurrentYear": -2.8427672, "fiftyDayAverageChange": 0.56938004, "fiftyDayAverageChangePercent": 0.14412422, "twoHundredDayAverageChange": 0.60336995, "twoHundredDayAverageChangePercent": 0.15405335, "trailingPegRatio": null, "__fetch_time": "2025-12-06"}]